Traditional Chinese medicine composition and preparation for treating diabetic retinopathy
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A technology for retinopathy and diabetes, applied in the field of traditional Chinese medicine compositions, can solve problems such as large side effects and can not completely prevent the growth of new blood vessels, and achieve the effects of stabilizing blood sugar, improving retinal ischemia and hypoxia, and reducing the generation of new blood vessels.
Inactive Publication Date: 2016-06-01
王萍
View PDF0 Cites 0 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
[0009] Panretinal photocoagulation is one of the effective measures to prevent blindness caused by diabetic retinopathy, but photocoagulation therapy alone cannot completely prevent the growth of new blood vessels, and has serious side effects
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0044] A kind of Chinese medicine composition for the treatment of diabetic retinopathy, said Chinese medicine composition comprises the raw material of following weight: Astragalus 9g, Angelica 12g, Scutellaria baicalensis 10g, Rehmannia glutinosa 10g, Scrophulariaceae 9g, Polygonatum 13g, Radix Puerariae 9g, Polygonum cuspidatum 12g, Alisma 10g, Digupi 12g, Rubia 9g, Sophora japonica 12g, Chrysanthemum 12g, Atractylodes macrocephala 9g, Chenpi 12g.
Embodiment 2
[0046] A kind of Chinese medicine composition for the treatment of diabetic retinopathy, said Chinese medicine composition comprises the raw material of following weight: astragalus 10g, angelica 10g, scutellaria baicalensis 12g, rehmannia glutinosa 12g, crocodile scrophulariae 10g, Polygonatum 12g, kudzu root 12g, Polygonum cuspidatum 10g, Alisma 12g, Digupi 10g, Rubia 12g, Sophora japonica 10g, Chrysanthemum 15g, Atractylodes macrocephala 10g, Chenpi 10g.
Embodiment 3
[0048] A kind of Chinese medicine composition for the treatment of diabetic retinopathy, said Chinese medicine composition comprises the raw material of following weight: astragalus 12g, angelica 9g, scutellaria baicalensis 9g, rehmannia root 9g, Scrophulariaceae 12g, Polygonatum 15g, Radix Puerariae 10g, Polygonum cuspidatum 9g, Alisma 9g, Digupi 9g, Rubia 10g, Sophora japonica 9g, Chrysanthemum 14g, Atractylodes macrocephala 12g, Chenpi 9g.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
PUM
Login to view more
Abstract
The invention relates to a traditional Chinese medicine composition, and in particular relates to a traditional Chinese medicine composition and preparation for treating diabetic retinopathy. The traditional Chinese medicine composition is prepared from the following raw materials: astragalus membranaceus, angelica sinensis, scutellaria baicalensis, dried rehmannia roots, scrophularia ningpoensis, radix polygonati officinalis, puerarin, polygonum cuspidatum, rhizoma alismatis, cortex lycii radicis, rubia cordifolia, sophora japonica, chrysanthemum, rhizoma atractylodis macrocephalae and pericarpium citri reticulatae. The traditional Chinese medicine preparation contains active components and pharmaceutically acceptable auxiliary materials; and the active components are the traditional Chinese medicine composition or extracts of the traditional Chinese medicine composition. The traditional Chinese medicine composition can achieve the aim of fast and effective treatment aiming at the disease, and is capable of obviously improving microcirculation to improve ischemia and hypoxia conditions of the retina when the diabetic retinopathy is treated, inhibiting formation of new blood vessels, relieving the pain of a patient and reducing other complications.
Description
technical field [0001] The invention relates to a traditional Chinese medicine composition, in particular to a traditional Chinese medicine composition and a preparation thereof for treating diabetic retinopathy. Background technique [0002] Diabetic patients mainly have abnormal insulin hormone and cell metabolism, which cause changes in eye tissue, nerve and blood vessel microcirculation, and cause damage to eye nutrition and visual function. Microvessels refer to microvessels and capillary networks with a lumen of less than 100-150 μm between tiny arteries and tiny veins, and are places where tissues and blood exchange substances. Due to the change of blood components in diabetic patients, the dysfunction of vascular endothelial cells is caused, which damages the blood-retinal barrier. The junctions between retinal capillary endothelial cells and pigment epithelial cells are disrupted, resulting in leakage of small blood vessels. Diabetic microangiopathy mainly occurs ...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to view more 
Login to view more